Professor Zielinski is Director of the Vienna Cancer Center (VCC) which coordinates cancer care and clinical trials within the City of Vienna. The VCC was founded in 2018. Since 1999, he is President of the Central European Cooperative Oncology Group (www.cecog.org) which is conducting clinical trials and major educational activities via its Academy in 23 countries of Central and Southeastern Europe.
Professor Zielinski completed his medical training at the University Hospital Vienna and began his career with a position as a research fellow at the Cancer Research Center at Tufts University, Boston, USA. From 2004 to 2017 he was chairman of the Department of Medicine I and its Clinical Division of Oncology and from 2010 to 2018 Director of the Comprehensive Cancer Center of the Medical University Vienna – General Hospital. His recent clinical research activities cover a wide range of cancer therapies, with particular focus on clinical trials, breast and lung cancer research including the development of concepts related to immune-oncology and targeted drugs. He has published ca. 600 original papers and reviews in peer-review journals and many books.
His h-Index is 67 and the citations of papers authored by him exceed 19.000.
Prof Zielinski is Editor in Chief of the peer review open-access internet journal “ESMO Open – Cancer Horizons” which is one of two scientific journals of the European Society for Medical Oncology published by the BMJ group, and – in this position - is member of the ESMO Council.
In 2013, Professor Zielinski received a “Dr. h.c.” degree from Titu Maiorescu University in Bucharest.
Professor Zielinski is a member of the European Society for Medical Oncology (ESMO) where he served on the Executive Board and as Chair of the Fellowships and Awards Committee from 2014-2017. He was Local Officer of the ESMO Annual Meeting 2012 and the ECC Meeting 2015.
Prof. Zielinski is an Honorary Member of the Polish Society for Clinical Oncology and also member of the Austrian Society for Hematology and Oncology, the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the Chinese Society for Clinical Oncology (CSCO).